Your browser doesn't support javascript.
loading
Vasovagal reactions after COVID-19 vaccination in Japan.
Okuyama, Mai; Morino, Saeko; Tanaka, Kaori; Nakamura-Miwa, Haruna; Takanashi, Sayaka; Arai, Satoru; Ochiai, Masaki; Ishii, Koji; Suzuki, Motoi; Oka, Akira; Morio, Tomohiro; Tanaka-Taya, Keiko.
Afiliación
  • Okuyama M; Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
  • Morino S; Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
  • Tanaka K; Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
  • Nakamura-Miwa H; Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
  • Takanashi S; Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
  • Arai S; Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
  • Ochiai M; Department of Quality Assurance, Radiation Safety, and Information System, National Institute of Infectious Diseases, Tokyo, Japan.
  • Ishii K; Department of Quality Assurance, Radiation Safety, and Information System, National Institute of Infectious Diseases, Tokyo, Japan.
  • Suzuki M; Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
  • Oka A; Department of Neurology, Saitama Children's Medical Center, Saitama, Japan.
  • Morio T; Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Tanaka-Taya K; Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan; Kanagawa Prefectural Institute of Public Health, Kanagawa, Japan. Electronic address: ktaya@niid.go.jp.
Vaccine ; 40(41): 5997-6000, 2022 09 29.
Article en En | MEDLINE | ID: mdl-36068111
ABSTRACT
Coronavirus disease 2019 (COVID-19) vaccine administration started in February 2021 in Japan. As of December 2021, approximately 75% of the population aged ≥12 years had received two doses of vaccine. We conducted a study to investigate vasovagal reactions (VVR) after COVID-19 vaccination using data on adverse events following immunization. The crude reporting rate of VVR (cases/1,000,000 doses) after vaccination was 9.6 in all age groups combined, and was more frequent in the younger age groups 28.6 and 37.2 in individuals aged 10-19 years and 20-29 years, respectively. In individuals aged 10-29 years, the rate was similar in males and females (33.0 and 34.2, respectively, p = 0.53); but was higher after dose 1 than after dose 2 (57.4 and 8.8, respectively, p < 0.001). Based on these results, caution needs to be exercised when vaccinating adolescents and young adults, especially with dose 1 of COVID-19 vaccines.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síncope Vasovagal / Vacunas contra la COVID-19 / COVID-19 Límite: Adolescent / Adult / Child / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síncope Vasovagal / Vacunas contra la COVID-19 / COVID-19 Límite: Adolescent / Adult / Child / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article País de afiliación: Japón